02162.HK
Keymed Biosciences Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 79.75
−0.99%Margins
Gross margin
82.1%
EBITDA margin
-49.3%
EBIT margin
-56.7%
Net margin
29.9%
FCF margin
-83.1%
12.7%
Return on equity
8.9%
Return on assets
-20.4%
Return on invested capital
0.34x
Asset turnover
-HKD 1.1B
Cash from operations
HKD 13
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026